| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | ITGR Integer Holdings Corp | Spence Donald J | Director | Sell | 14,739 | $120.38 | $1,774,339.78 | -44.0% | -11.0% | -22.8% | |
| Jun 4, 2025 | NMTC Neuroone Medical Technologies Corp | Christianson Mark67 | Business Development Director | Sell | 10,000 | $0.58 | $5,804.00 | -3.7% | +19.7% | +478.0% | |
| Jun 4, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J49 | President And CEO | Buy | 8,000 | $0.66 | $5,280.00 | - | +18.3% | -1.9% | |
| Jun 4, 2025 | MASS 908 Devices Inc. | Griffith Joseph H. IV81 | Chief Financial Officer | Sell | 6,940 | $7.08 | $49,135.20 | -6.3% | -13.9% | +27.8% | |
| Jun 4, 2025 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 2,000 | $247.32 | $494,640.00 | -2.8% | +8.4% | -22.3% | |
| Jun 4, 2025 | BSX Boston Scientific Corp | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Sell | 56,372 | $102.88 | $5,799,630.28 | -24.0% | +4.1% | -52.3% | |
| Jun 4, 2025 | MLSS Milestone Scientific Inc. | Bp4 S.r.l.89 | 10% Owner | Sell | 14,000 | $0.93 | $12,963.00 | - | -34.2% | -52.7% | |
| Jun 4, 2025 | ISRG Intuitive Surgical Inc | Brosius Mark56 | SVP &Chief Mfg And Supply Cha | Sell | 645 | $550.60 | $355,139.15 | -12.2% | -15.9% | -24.9% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Stafford Kristin | Director | Sell | 999 | $17.28 | $17,258.92 | -24.6% | -28.5% | +0.0% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Ocean Allyson J | Director | Sell | 999 | $17.29 | $17,269.01 | -24.6% | -28.5% | +0.0% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Leung Gabriel78 | Director | Sell | 999 | $17.31 | $17,297.29 | -1.2% | -28.5% | +0.0% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Vernon W Anthony | Director | Sell | 999 | $17.35 | $17,329.25 | -0.6% | -28.5% | +0.0% | |
| Jun 3, 2025 | INCY Incyte Corp | Denton Sheila A. | EVP &General Counsel | Sell | 1,795 | $68.00 | $122,060.00 | -6.3% | +28.1% | +37.4% | |
| Jun 3, 2025 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 239 | $7.25 | $1,732.97 | -0.7% | -19.5% | -90.7% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Scannell Timothy J | Director | Sell | 999 | $17.32 | $17,299.18 | -14.2% | -28.5% | +0.0% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Hilleman Jeryl L61 | Director | Sell | 999 | $17.26 | $17,246.54 | -15.2% | -28.5% | +0.0% | |
| Jun 3, 2025 | CBLL Ceribell, Inc. | Chao Xingjuan54 | President And CEO | Sell | 25,000 | $17.00 | $425,000.00 | -3.1% | -32.5% | +1.5% | |
| Jun 3, 2025 | CLPT Clearpoint Neuro, Inc. | Fallon Lynnette C52 | Director | Sell | 10,200 | $12.57 | $128,226.00 | -10.9% | -17.6% | +5.1% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Hung David66 | Director | Sell | 999 | $17.30 | $17,279.50 | -7.6% | -28.5% | +0.0% | |
| Jun 3, 2025 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 463 | $7.22 | $3,342.54 | -0.9% | -19.5% | -90.7% | |
| Jun 3, 2025 | NVCR Novocure Ltd | Madden Martin J. | Director | Sell | 999 | $17.19 | $17,175.61 | -5.1% | -28.5% | +0.0% | |
| Jun 3, 2025 | IRIX Iridex Corp | Dizon Romeo R61 | Chief Financial Officer | Buy | 200 | $1.00 | $199.00 | +0.8% | +39.1% | +15.6% | |
| Jun 3, 2025 | EW Edwards Lifesciences Corp | Zovighian Bernard J55 | CEO | Sell | 17,066 | $77.22 | $1,317,836.50 | -48.4% | +5.2% | +10.7% | |
| Jun 3, 2025 | SGHT Sight Sciences, Inc. | Encrantz Staffan74 | Director, 10% Owner | Buy | 98,782 | $3.81 | $376,429.44 | +2.8% | -3.7% | +12.9% | |
| Jun 2, 2025 | CTKB Cytek Biosciences, Inc. | McCombe William D.77 | Chief Financial Officer | Buy | 35,000 | $2.78 | $97,300.00 | +168.7% | +42.0% | +48.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.